At any given time, an estimated 15% of the US adult population has chronic kidney disease (CKD). It manifests as reduced kidney function to below 60% of its normal range (estimated glomerular filtration rate < 60 mL/min/1.73 m2) or by spillage of protein into the urine. The many causes of CKD include diabetes, hypertension, glomerulonephritis, and cystic kidney diseases. CKD is an irreversible malady with no known cure, and it invariably worsens over time. CKD is associated with higher mortality risks as it advances. If the patient does not die of cardiovascular or infectious events, end-stage renal disease ensues and the patient requires maintenance dialysis therapy or kidney transplantation to survive.
Each year, 130,000 Americans transition to dialysis, which is not only costly but also associated with poor health-related quality of life and an early mortality of more than 20% in the first year. Hence, slowing CKD progression and preventing or delaying dialysis can have major favorable implications for CKD outcomes.
There has been growing recognition that conservative management, including kidney-preserving strategies without dialysis, is a viable patient-centered treatment option for many people with CKD. The kidney-preserving approach of conservative therapy, which differs from supportive or palliative care, can be achieved by pharmacologic interventions.
COMMENTARY
How a Low-Protein Diet Can Delay Dialysis in Patients With Chronic Kidney Disease
Kam Kalantar-Zadeh, MD, MPH, PhD
DisclosuresNovember 05, 2021
At any given time, an estimated 15% of the US adult population has chronic kidney disease (CKD). It manifests as reduced kidney function to below 60% of its normal range (estimated glomerular filtration rate < 60 mL/min/1.73 m2) or by spillage of protein into the urine. The many causes of CKD include diabetes, hypertension, glomerulonephritis, and cystic kidney diseases. CKD is an irreversible malady with no known cure, and it invariably worsens over time. CKD is associated with higher mortality risks as it advances. If the patient does not die of cardiovascular or infectious events, end-stage renal disease ensues and the patient requires maintenance dialysis therapy or kidney transplantation to survive.
Each year, 130,000 Americans transition to dialysis, which is not only costly but also associated with poor health-related quality of life and an early mortality of more than 20% in the first year. Hence, slowing CKD progression and preventing or delaying dialysis can have major favorable implications for CKD outcomes.
There has been growing recognition that conservative management, including kidney-preserving strategies without dialysis, is a viable patient-centered treatment option for many people with CKD. The kidney-preserving approach of conservative therapy, which differs from supportive or palliative care, can be achieved by pharmacologic interventions.
Credits:
Lead Image: E+/Getty Images
Medscape Nephrology © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: How a Low-Protein Diet Can Delay Dialysis in Patients With Chronic Kidney Disease - Medscape - Nov 05, 2021.
Tables
Authors and Disclosures
Authors and Disclosures
Authors
Kam Kalantar-Zadeh, MD, MPH, PhD
Chief, Division of Nephrology, Hypertension and Kidney Transplantation; Tenured Professor of Medicine, Pediatrics, Public Health and Nursing Sciences, University of California, Irvine, School of Medicine, Orange, California
Disclosure: Kam Kalantar-Zadeh, MD, MPH, PhD, reports the following relevant financial relationships:
Received honoraria and/or support from: Akebia; Ardelyx; Astra-Zeneca; Daiichi; DaVita; Fresenius; Haymarket Media; Kabi; Novartis; Novo-Nordisk; Pfizer; Resverlogix; Sanofi